A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls

BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Bartlett, David B., Connelly, Margery A., AbouAssi, Hiba, Bateman, Lori A., Tune, K. Noelle, Huebner, Janet L., Kraus, Virginia B., Winegar, Deborah A., Otvos, James D., Kraus, William E., Huffman, Kim M.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828830/
https://ncbi.nlm.nih.gov/pubmed/27067270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0982-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars